Tissue | Expression Dynamics | Abbreviation |
Colorectum (GSE201348) | | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Endometrium | | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Thyroid | | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:19017992 | Colorectum | MSS | negative regulation of proteasomal protein catabolic process | 19/3467 | 49/18723 | 7.20e-04 | 7.70e-03 | 19 |
GO:00181052 | Colorectum | MSS | peptidyl-serine phosphorylation | 81/3467 | 315/18723 | 8.92e-04 | 9.12e-03 | 81 |
GO:00182091 | Colorectum | MSS | peptidyl-serine modification | 84/3467 | 338/18723 | 2.12e-03 | 1.79e-02 | 84 |
GO:00105071 | Colorectum | MSS | negative regulation of autophagy | 26/3467 | 85/18723 | 4.84e-03 | 3.38e-02 | 26 |
GO:0071480 | Colorectum | MSS | cellular response to gamma radiation | 12/3467 | 31/18723 | 6.80e-03 | 4.39e-02 | 12 |
GO:00421764 | Colorectum | FAP | regulation of protein catabolic process | 106/2622 | 391/18723 | 5.00e-12 | 3.06e-09 | 106 |
GO:00098954 | Colorectum | FAP | negative regulation of catabolic process | 91/2622 | 320/18723 | 9.66e-12 | 4.96e-09 | 91 |
GO:00313304 | Colorectum | FAP | negative regulation of cellular catabolic process | 77/2622 | 262/18723 | 6.79e-11 | 2.31e-08 | 77 |
GO:00431614 | Colorectum | FAP | proteasome-mediated ubiquitin-dependent protein catabolic process | 98/2622 | 412/18723 | 5.41e-08 | 4.20e-06 | 98 |
GO:00105063 | Colorectum | FAP | regulation of autophagy | 80/2622 | 317/18723 | 6.43e-08 | 4.54e-06 | 80 |
GO:19033624 | Colorectum | FAP | regulation of cellular protein catabolic process | 68/2622 | 255/18723 | 6.50e-08 | 4.54e-06 | 68 |
GO:00104984 | Colorectum | FAP | proteasomal protein catabolic process | 110/2622 | 490/18723 | 2.12e-07 | 1.26e-05 | 110 |
GO:20000584 | Colorectum | FAP | regulation of ubiquitin-dependent protein catabolic process | 48/2622 | 164/18723 | 2.88e-07 | 1.63e-05 | 48 |
GO:00421774 | Colorectum | FAP | negative regulation of protein catabolic process | 38/2622 | 121/18723 | 7.10e-07 | 3.32e-05 | 38 |
GO:19033634 | Colorectum | FAP | negative regulation of cellular protein catabolic process | 25/2622 | 75/18723 | 1.74e-05 | 4.42e-04 | 25 |
GO:19030504 | Colorectum | FAP | regulation of proteolysis involved in cellular protein catabolic process | 54/2622 | 221/18723 | 2.26e-05 | 5.32e-04 | 54 |
GO:00181053 | Colorectum | FAP | peptidyl-serine phosphorylation | 71/2622 | 315/18723 | 2.51e-05 | 5.82e-04 | 71 |
GO:00182092 | Colorectum | FAP | peptidyl-serine modification | 73/2622 | 338/18723 | 8.47e-05 | 1.51e-03 | 73 |
GO:00324344 | Colorectum | FAP | regulation of proteasomal ubiquitin-dependent protein catabolic process | 35/2622 | 134/18723 | 1.48e-04 | 2.29e-03 | 35 |
GO:00063253 | Colorectum | FAP | chromatin organization | 84/2622 | 409/18723 | 1.62e-04 | 2.47e-03 | 84 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TLK2 | SNV | Missense_Mutation | novel | c.1820N>C | p.Gly607Ala | p.G607A | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
TLK2 | SNV | Missense_Mutation | | c.1219N>C | p.Glu407Gln | p.E407Q | Q86UE8 | protein_coding | deleterious(0.01) | benign(0.371) | TCGA-A2-A0CX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
TLK2 | SNV | Missense_Mutation | | c.1730N>T | p.Ala577Val | p.A577V | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.926) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TLK2 | SNV | Missense_Mutation | | c.1658A>G | p.Asp553Gly | p.D553G | Q86UE8 | protein_coding | deleterious(0) | possibly_damaging(0.685) | TCGA-D8-A1XC-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
TLK2 | SNV | Missense_Mutation | novel | c.93N>G | p.Asn31Lys | p.N31K | Q86UE8 | protein_coding | deleterious_low_confidence(0.02) | benign(0.007) | TCGA-PE-A5DC-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
TLK2 | SNV | Missense_Mutation | novel | c.1703G>A | p.Arg568Gln | p.R568Q | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.909) | TCGA-UL-AAZ6-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | herceptin | SD |
TLK2 | SNV | Missense_Mutation | rs200158456 | c.127N>A | p.Gly43Arg | p.G43R | Q86UE8 | protein_coding | deleterious_low_confidence(0) | probably_damaging(1) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TLK2 | SNV | Missense_Mutation | novel | c.1864G>T | p.Asp622Tyr | p.D622Y | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.928) | TCGA-C5-A8XI-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | SD |
TLK2 | SNV | Missense_Mutation | | c.857G>C | p.Arg286Thr | p.R286T | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-JX-A3Q0-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
TLK2 | SNV | Missense_Mutation | | c.1801N>C | p.Val601Leu | p.V601L | Q86UE8 | protein_coding | tolerated(0.24) | probably_damaging(0.981) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |